Amy L (Ericson) Helgerson

Title: Amy L (Ericson) Helgerson: Innovator in Viral Purification Technologies

Introduction

Amy L (Ericson) Helgerson is a notable inventor based in Charlton, MA (US). She has made significant contributions to the field of viral purification, particularly in therapeutic applications. Her work focuses on improving methods for purifying adenovirus and adeno-associated virus (AAV), which are crucial for gene therapy procedures.

Latest Patents

Amy Helgerson holds a patent for the "Purification of adenovirus and AAV." This invention relates to the purification of large-scale quantities of active (infectious) adenovirus and AAV. The methods she developed minimize or eliminate damage to the virus during purification, allowing for the rapid and efficient production of commercial-level quantities suitable for therapeutic use.

Career Highlights

Helgerson is associated with Genzyme Corporation, where she has been instrumental in advancing viral purification technologies. Her innovative approaches have paved the way for more effective gene transfer and therapy procedures, enhancing the potential for medical advancements in this area.

Collaborations

Throughout her career, Amy has collaborated with esteemed colleagues, including Catherine E O'Riordan and Alan E Smith. These partnerships have contributed to the success of her research and the development of her patented technologies.

Conclusion

Amy L (Ericson) Helgerson is a pioneering inventor whose work in viral purification has significant implications for therapeutic applications. Her contributions continue to influence the field and enhance the effectiveness of gene therapy procedures.